Article info
Original article
Clinicopathological significance of Necl-4 expression in pancreatic ductal adenocarcinoma
- Correspondence to Dr Kenichi Hirabayashi, Department of Pathology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan; kenichi.hirabayashi{at}tokai.ac.jp
Citation
Clinicopathological significance of Necl-4 expression in pancreatic ductal adenocarcinoma
Publication history
- Received July 14, 2016
- Revised November 10, 2016
- Accepted November 27, 2016
- First published December 15, 2016.
Online issue publication
June 14, 2020
Article Versions
- Previous version (22 June 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/